AstraZeneca to Pay $520 Million in Seroquel Marketing Case
 From Associated Press (April 27, 2010)

The U.S. government yesterday reached a $520 million settlement with 
Britain's AstraZeneca, resolving allegations of illegal marketing of 
the company's antipsychotic drug Seroquel. At a news conference, 
Attorney General Eric Holder and HHS Secretary Kathleen Sebelius made 
the case a centerpiece of the federal government's crackdown on 
health care fraud. AstraZeneca allegedly marketed Seroquel for 
off-label uses -- those not approved by federal drug regulators -- 
including insomnia and psychiatric conditions other than 
schizophrenia and bipolar disorder.

www.peoplewho.org